| |
|
|
|
|
|
|
|||
|
M Beran, KB McCredie, MJ Keating and JU Gutterman
University of Texas M.D. Anderson Hospital and Tumor Institute, Department
of Hematology, Houston 77030.
The effect of recombinant human tumor necrosis factor alpha (rTNF- alpha)
on human myelogenous leukemia clonogenic cells growing either in semisolid
media or in suspension cultures was studied and compared with the effect on
normal granulocyte-macrophage progenitors (GM-CFC). Exposure of cells to a
range of rTNF-alpha doses including pharmacologically achievable plasma
concentrations revealed a large heterogeneity in the response of leukemic
clonogenic growth to rTNF- alpha. Only one of 13 specimens was highly
resistant to rTNF-alpha. Eight of ten leukemic samples were significantly
more sensitive than were normal GM-CFC, particularly within the in vivo
achievable dose range (1 x 10(0) to 1 x 10(2) ng/mL). No significantly
increased inhibition of either normal or leukemic clonogenic growth could
be achieved by increasing the rTNF-alpha concentration above 250 ng/mL.
Proliferation of leukemic clonogenic cells (L-CFC) was studied in
suspension cultures. In five cases the clonogenic cells were significantly
inhibited by rTNF-alpha while in one case no inhibition was observed. The
inhibition of L-CFC growth by rTNF-alpha was dose dependent between 1 x
10(0) and 1 x 10(2) ng/mL. In suspension cultures, the TNF effect on L-CFC
was a function of time of exposure, particularly with low concentrations of
TNF. A remarkably higher inhibition of L-CFC as compared with the total
leukemic population was observed in suspension cultures. Stimulation of
L-CFC growth by rTNF- alpha was not observed. Normal GM-CFC were inhibited
by alpha and gamma interferons (INF-alpha, -gamma) in a dose-related
manner, with higher sensitivity of colonies than clusters. The response of
GM-CFC to combination of recombinant IFNs and TNF was influenced by the
size of clones scored and the source of colony-stimulating activity. The
response of L-CFC to recombinant IFN-alpha and/or -gamma was highly
variable, and sensitivity to one of the lymphokines did not predict for
sensitivity to another. The response of L-CFC to combinations of rTNF-
alpha and either IFN-alpha or IFN-gamma was complex, varying from
synergistic to additive and indifferent. In three of six specimens, IFN-
gamma acted antagonistically with rTNF-alpha, a phenomenon not observed
with IFN-alpha. These observations suggest that the action of rTNF- alpha
in acute myelogenous leukemia could be exploited therapeutically and the
dose-time-response relationship should be considered in designing treatment
schedules.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
| |||||||||||
| Copyright © 1988 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||